Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive modelPau Montesinos, Miguel Á. Sanz, Javier de la Rubia et al.|Haematologica|2007Cited by 225
Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopeniaTadeusz Robak, Stephen Jolles, Maciej Kaźmierczak et al.|Blood Advances|2020Cited by 109
Cord Blood Transplantation from Unrelated Donors in Adults with High-Risk Acute Myeloid LeukemiaJaime Sanz, Guillermo Sanz, Miguel Á. Sanz et al.|Biology of Blood and Marrow Transplantation|2009Cited by 78
Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantationNoemí Puig, Miguel Á. Sanz, Javier de la Rubia et al.|Leukemia & lymphoma/Leukemia and lymphoma|2006Cited by 69
EBV-associated post-transplant lymphoproliferative disorder after umbilical cord blood transplantation in adults with hematological diseasesJaime Sanz, Guillermo Sanz, Marcos Arango et al.|Bone Marrow Transplantation|2013Cited by 67